← Leaderboards
John H. McCusker
Duke University
$7,395,397
Attributed
$8,952,036
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $844.9K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,952,036 · 8
By mechanism
R01$8,375,988 · 6
R21$424,554 · 1
P01$151,494 · 1
Top collaborators
- Fred S Dietrich4 shared
- Paul Mitaari Magwene4 shared
- Eric A Stone4 shared
Most similar at Duke University
Same institution · by research overlap
- Stuart M Levitz$22,736,478
- Thuy Le$9,408,752
- P.j. Eric Stallard$5,835,509
- Joseph Heitman$44,576,851
- Ashutosh Chilkoti$32,367,884
Others in their field
Top investigators on “Saccharomyces Cerevisiae”
- Ronald Wayne Davis · Stanford University$52,493,521
- Joe Michael Cherry · Stanford University$41,714,975
- Hiten D Madhani · University Of California, San Francisco$22,022,983
- Mark Hochstrasser · University Of Chicago$20,852,291
- Stephen K Burley · Rockefeller University$20,385,391
- Richard D Kolodner · Dana-Farber Cancer Institute$19,307,749
Research focus
Saccharomyces CerevisiaeVirulencePhenotypeGenomeGenotypeTraitGenesGeneticGrowthMolecular CloningBaseFungal GeneticsHigh Temperature Of Physical ObjectGenome SequencingQuantitative Trait LociPathogenQuantitative GeneticsGene MutationAntifungal AgentsLaboratory MouseGene ExpressionHereditary DiseaseInsightNucleic Acid Sequence
Grant awards (30)
Nuclear, mitochondrial and L-A virus contributions to yeast quantitative traits$413,400
R01 · FY2020 · GM · contact PI
Nuclear, mitochondrial and L-A virus contributions to yeast quantitative traits$413,400
R01 · FY2019 · GM · contact PI
Nuclear, mitochondrial and L-A virus contributions to yeast quantitative traits$413,400
R01 · FY2018 · GM · contact PI
Nuclear, mitochondrial and L-A virus contributions to yeast quantitative traits$409,622
R01 · FY2017 · GM · contact PI
High throughput S. cerevisiae HAM, GWA & QT/QTL architecture$411,163
R01 · FY2014 · GM · contact PI
High throughput S. cerevisiae HAM, GWA & QT/QTL architecture$406,347
R01 · FY2013 · GM · contact PI
High throughput S. cerevisiae HAM, GWA & QT/QTL architecture$664,995
R01 · FY2012 · GM · contact PI
High throughput S. cerevisiae HAM, GWA & QT/QTL architecture$593,014
R01 · FY2011 · GM · contact PI
ANALYSIS OF GENETICALLY & ENVIRONMENTALLY OVERLAPPING YEAST QUANTITATIVE TRAITS$349,638
R01 · FY2010 · GM · contact PI
ANALYSIS OF GENETICALLY & ENVIRONMENTALLY OVERLAPPING YEAST QUANTITATIVE TRAITS$342,887
R01 · FY2009 · GM · contact PI
S. Cerevisiae Emergence of an Opportunistic Pathogen$98,012
R01 · FY2009 · GM · contact PI
ANALYSIS OF GENETICALLY & ENVIRONMENTALLY OVERLAPPING YEAST QUANTITATIVE TRAITS$332,898
R01 · FY2008 · GM · contact PI
S. Cerevisiae Emergence of an Opportunistic Pathogen$252,219
R01 · FY2008 · GM · contact PI
Fungal-specific drug targets: static vs. cidal starvation & toxic intermediates$229,554
R21 · FY2008 · AI · contact PI
ANALYSIS OF GENETICALLY & ENVIRONMENTALLY OVERLAPPING YEAST QUANTITATIVE TRAITS$339,754
R01 · FY2007 · GM · contact PI
S. Cerevisiae Emergence of an Opportunistic Pathogen$310,168
R01 · FY2007 · GM · contact PI
Fungal-specific drug targets: static vs. cidal starvation & toxic intermediates$195,000
R21 · FY2007 · AI · contact PI
S. Cerevisiae Emergence of an Opportunistic Pathogen$352,042
R01 · FY2006 · GM · contact PI
S. Cerevisiae Emergence of an Opportunistic Pathogen$344,210
R01 · FY2005 · GM
PHASE VARIATION IN SACCHAROMYCES CEREVISIAE$282,049
R01 · FY2003 · GM
GENETIC DIVERSITY AND COMPLEX TRAITS IN S CEREVISIAE$283,402
R01 · FY2002 · GM
PHASE VARIATION IN SACCHAROMYCES CEREVISIAE$273,923
R01 · FY2002 · GM
GENETIC IDENTIFICATION OF ANTIFUNGAL DRUG TARGETS$0
P01 · FY2002 · AI
GENETIC IDENTIFICATION OF ANTIFUNGAL DRUG TARGETS$0
P01 · FY2002 · AI
GENETIC DIVERSITY AND COMPLEX TRAITS IN S CEREVISIAE$276,649
R01 · FY2001 · GM
PHASE VARIATION IN SACCHAROMYCES CEREVISIAE$271,094
R01 · FY2001 · GM
GENETIC IDENTIFICATION OF ANTIFUNGAL DRUG TARGETS$0
P01 · FY2001 · AI
GENETIC DIVERSITY AND COMPLEX TRAITS IN S CEREVISIAE$272,055
R01 · FY2000 · GM
PHASE VARIATION IN SACCHAROMYCES CEREVISIAE$269,647
R01 · FY2000 · GM
GENETIC IDENTIFICATION OF ANTIFUNGAL DRUG TARGETS$151,494
P01 · FY2000 · AI